Obesity & Overweight study: Intervention vs Incretin-Based Treatment
Official title Incretin-based Therapies, Nutrition, and Physical Activity
ClinicalTrials.gov ID: NCT07409831
What this study is testing
What is Incretin-Based Treatment?
This is an investigational medication being studied to help manage obesity and overweight. It is designed to help regulate blood sugar and reduce appetite by mimicking natural hormones released after eating.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether adding exercise and diet helps keep muscle. It also checks if a new care model works well.
- Who it's for
- You may be able to join if you are an adult with obesity.
- What's involved
- You would take weight-loss medicine. You might also join a six-month exercise and diet program.
- Time commitment
- The study lasts one year with check-ins at 3, 6, and 12 months.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Adults aged 18 to 70 years
- BMI \>30 kg/m2, or
- BMI \>27 kg/m2 with presence of comorbidities (e.g., type II diabetes, hypertension, hypercholesterolemia)
You likely can't join if
- Medical contraindications to physical activity practice (e.g., unstable cardiovascular disease, severe orthopedic limitation)
- Prior or ongoing incretin-based therapy or history of bariatric surgery
- Pregnancy, current breastfeeding or planned pregnancy during the study period
- Implemented medical devices (e.g. pacemaker, defibrillator)
- Chronic conditions affecting protein metabolism or nutrition (e.g., advanced kidney disease, active cancer)
The study team makes the final eligibility decision.
Where it is enrolling
- Québec, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Québec, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.